Study Comparing Pembrolizumab With Methotrexate in Elderly, Frail or Cisplatin-ineligible Patients With Head and Neck Cancers

Condition:   Cancer of Head and Neck
Interventions:   Drug: Pembrolizumab Injection;   Drug: Methotrexate Injectable Solution
Sponsor:   AIO-Studien-gGmbH
Not yet recruiting - verified June 2017

http://ift.tt/2tsZtul